Regulation of cortisol bioavailability - Effects on hormone measurement and action

Nature Reviews Endocrinology

Volumn 8, Issue 12, 2012, Pages 717-727

  Perogamvros, Ilias ^a   Ray, David W ^a   Trainer, Peter J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CORTICOSTERONE; CORTISONE; CORTODOXONE; DEXAMETHASONE; ESTROGEN; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; INTERLEUKIN 6; LEUKOCYTE ELASTASE; MITOTANE; PREDNISOLONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN C; THYROID HORMONE; TRANSCORTIN;

ADRENAL INSUFFICIENCY; BINDING AFFINITY; BIOAVAILABILITY; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; ENZYME DEGRADATION; EXTRACELLULAR SPACE; HEREDITY; HORMONE ACTION; HORMONE BINDING; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE STRUCTURE; HORMONE TRANSPORT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; LIVER CIRRHOSIS; NEPHROTIC SYNDROME; PREGNANCY; PRIORITY JOURNAL; REVIEW; SALIVA ANALYSIS; SEPSIS; TISSUE SPECIFICITY;

ANIMALS; BIOLOGICAL AVAILABILITY; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; TRANSCORTIN;

EID: 84870054439     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2012.134     Document Type: Review

References (124)

1. Lewis, J. G., Bagley, C. J., Elder, P. A., Bachmann, A. W. & Torpy, D. J. Plasma free cortisol fraction reflects levels of functioning corticosteroid-binding globulin. Clin. Chim. Acta 359, 189-194 (2005).
2. Mendel, C. M. The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 10, 232-274 (1989).
3. Htun, H., Barsony, J., Renyi, I., Gould, D. L. & Hager, G. L. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl Acad. Sci. USA 93, 4845-4850 (1996).
4. Rhen, T. & Cidlowski, J. A. Anti-inflammatory action of glucocorticoids-new mechanisms for old drugs. N. Engl. J. Med. 353, 1711-1723 (2005).
5. Chrousos, G. P. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 5, 374-81 (2009).
6. Mendel, C. M. The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J. Androl. 13, 107-116 (1992).
7. Mendel, C. M. et al. Uptake of cortisol by the perfused rat liver: validity of the free hormone hypothesis applied to cortisol. Endocrinology 124, 468-476 (1989).
8. Hryb, D. J. et al. Specific binding of human corticosteroid-binding globulin to cell membranes. Proc. Natl Acad. Sci. USA 83, 3253-3256 (1986).
9. Nakhla, A. M., Khan, M. S. & Rosner, W. Induction of adenylate cyclase in a mammary carcinoma cell line by human corticosteroid-binding globulin. Biochem. Biophys. Res. Commun. 153, 1012-1018 (1988).
10. Willnow, T. E. & Nykjaer, A. Cellular uptake of steroid carrier proteins-mechanisms and implications. Mol. Cell Endocrinol. 316, 93-102 (2010).
11. Rosner, W., Hryb, D. J., Kahn, S. M., Nakhla, A. M. & Romas, N. A. Interactions of sex hormone-binding globulin with target cells. Mol. Cell Endocrinol. 316, 79-85 (2010).
12. Cameron, A. et al. Temperature-responsive release of cortisol from its binding globulin: a protein thermocouple. J. Clin. Endocrinol. Metab. 95, 4689-4695 (2010).
13. Westphal, U. Steroid-protein interaction: from past to present. J. Steroid Biochem. 19, 1-15 (1983).
14. Cooper, M. S. & Stewart, P. M. 11β-Hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation. J. Clin. Endocrinol. Metab. 94, 4645-4654 (2009).
15. Edwards, C. R. et al. Localisation of 11 β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2, 986-989 (1988).
16. Smith, R. E. et al. Localization of 11 β-hydroxysteroid dehydrogenase type II in human epithelial tissues. J. Clin. Endocrinol. Metab. 81, 3244-3248 (1996).
17. Stewart, P. M. Cortisol as a mineralocorticoid in human disease. J. Steroid Biochem. Mol. Biol. 69, 403-408 (1999).
18. Hammond, G. L., Smith, C. L. & Underhill, D. A. Molecular studies of corticosteroid binding globulin structure, biosynthesis and function. J. Steroid Biochem. Mol. Biol. 40, 755-762 (1991).
19. Pugeat, M. M., Dunn, J. F. & Nisula, B. C. Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J. Clin. Endocrinol. Metab. 53, 69-75 (1981).
20. Dunn, J. F., Nisula, B. C. & Rodbard, D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J. Clin. Endocrinol. Metab. 53, 58-68 (1981).
21. Lightman, S. L. & Conway-Campbell, B. L. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat. Rev. Neurosci. 11, 710-718 (2010).
22. Pugeat, M. M. et al. Plasma cortisol transport and primate evolution. Endocrinology 115, 357-361 (1984).
23. Lin, H. Y., Muller, Y. A. & Hammond, G. L. Molecular and structural basis of steroid hormone binding and release from corticosteroid-binding globulin. Mol. Cell Endocrinol. 316, 3-12 (2010).
24. Pemberton, P. A., Stein, P. E., Pepys, M. B., Potter, J. M. & Carrell, R. W. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336, 257-258 (1988).
25. Hammond, G. L., Smith, C. L., Paterson, N. A. & Sibbald, W. J. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J. Clin. Endocrinol. Metab. 71, 34-39 (1990).
26. Emptoz-Bonneton, A., Crave, J. C., Lejeune, H., Brebant, C. & Pugeat, M. Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells. J. Clin. Endocrinol. Metab. 82, 3758-3762 (1997).
27. Tsigos, C., Kyrou, I., Chrousos, G. P. & Papanicolaou, D. A. Prolonged suppression of corticosteroid-binding globulin by recombinant human interleukin-6 in man. J. Clin. Endocrinol. Metab. 83, 3379 (1998).
28. Ho, J. T. et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J. Clin. Endocrinol. Metab. 91, 105-114 (2006).
29. Bernier, J., Jobin, N., Emptoz-Bonneton, A., Pugeat, M. M. & Garrel, D. R. Decreased corticosteroid-binding globulin in burn patients: relationship with interleukin-6 and fat in nutritional support. Crit. Care Med. 26, 452-460 (1998).
30. Zouaghi, H. et al. Total and unbound cortisol-, progesterone-, oestrone-and transcortin-binding activities in sera from patients with myocardial infarction: evidence for differential responses of good and bad prognostic cases. Eur. J. Clin. Invest. 15, 365-370 (1985).
31. Westphal, U. Steroid-protein interactions. Monogr. Endocrinol. 4, 1-567 (1971).
32. Lin, H. Y. et al. High frequency of SERPINA6 polymorphisms that reduce plasma corticosteroid-binding globulin activity in Chinese subjects. J. Clin. Endocrinol. Metab. 94, E678-E686 (2012).
33. Gagliardi, L., Ho, J. T. & Torpy, D. J. Corticosteroid-binding globulin: the clinical significance of altered levels and heritable mutations. Mol. Cell. Endocrinol. 316, 24-34 (2010).
34. Musa, B. U., Seal, U. S. & Doe, R. P. Elevation of certain plasma proteins in man following estrogen administration: a dose-response relationship. J. Clin. Endocrinol. Metab. 25, 1163-1166 (1965).
35. Sandberg, A. A. & Slaunwhite, W. R. Transcortin: a corticosteroid-binding protein of plasma. II. Levels in various conditions and the effects of estrogens. J. Clin. Invest. 38, 1290-1297 (1959).
36. Mitchell, E., Torpy, D. J. & Bagley, C. J. Pregnancy-associated corticosteroid-binding globulin: high resolution separation of glycan isoforms. Horm. Metab. Res. 36, 357-359 (2004).
37. Strel'chyonok, O. A. & Avvakumov, G. V. Specific steroid-binding glycoproteins of human blood plasma: novel data on their structure and function. J. Steroid Biochem. 35, 519-534 (1990).
38. Nader, N. et al. Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans. J. Clin. Endocrinol. Metab. 91, 2165-2170 (2006).
39. Alexandraki, K. I. et al. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. Clin. Endocrinol. (Oxf.) 72, 305-311 (2010).
40. Klose, M. et al. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J. Clin. Endocrinol. Metab. 92, 1326-1333 (2007).
41. Perogamvros, I., Keevil, B. G., Ray, D. W. & Trainer, P. J. Salivary cortisone is a potential biomarker for serum free cortisol. J. Clin. Endocrinol. Metab. 95, 4951-4958 (2010).
42. Plumpton, F. S. & Besser, G. M. The adrenocortical response to surgery and insulin-induced hypoglycemia in corticosteroid-treated and normal subjects. Br. J. Surg. 55, 857 (1968).
43. Widmer, I. E. et al. Cortisol response in relation to the severity of stress and illness. J. Clin. Endocrinol. Metab. 90, 4579-4586 (2005).
44. Vogeser, M. et al. Corticosteroid-binding globulin and free cortisol in the early postoperative period after cardiac surgery. Clin. Biochem. 32, 213-216 (1999).
45. Vogeser, M., Briegel, J. & Zachoval, R. Dialyzable free cortisol after stimulation with Synacthen. Clin. Biochem. 35, 539-543 (2002).
46. Christ-Crain, M. et al. Measurement of serum free cortisol shows discordant responsivity to stress and dynamic evaluation. J. Clin. Endocrinol. Metab. 92, 1729-1735 (2007).
47. Thomson, A. H. et al. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency. Clin. Endocrinol. (Oxf.) 66, 789-796 (2007).
48. Wong, V., Yan, T., Donald, A. & McLean, M. Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients. Clin. Endocrinol. (Oxf.) 61, 131-137 (2004).
49. Nieman, L. K. et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93, 1526-1540 (2008).
50. Raff, H. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. J. Clin. Endocrinol. Metab. 94, 3647-3655 (2009).
51. Baid, S. K., Sinaii, N., Wade, M., Rubino, D. & Nieman, L. K. Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J. Clin. Endocrinol. Metab. 92, 3102-3107 (2007).
52. Annane, D. et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288, 862-871 (2002).
53. Marik, P. E. et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit. Care Med. 36, 1937-1949 (2008).
54. Annane, D., Sébille, V., Troché, G., Raphaël, J. C., Gajdos, P. & Bellissant, E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283, 1038-1045.
55. Mickelson, K. E., Forsthoefel, J. & Westphal, U. Steroid-protein interactions. Human corticosteroid binding globulin: some physicochemical properties and binding specificity. Biochemistry 20, 6211-6218 (1981).
56. Vogeser, M. & Briegel, J. Effect of temperature on protein binding of cortisol. Clin. Biochem. 40, 724-727 (2007).
57. Hammond, G. L. Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins. Endocr. Rev. 11, 65-79 (1990).
58. Sprung, C. L. et al. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 358, 111-124 (2008).
59. Hamrahian, A. H., Oseni, T. S. & Arafah, B. M. Measurements of serum free cortisol in critically ill patients. N. Engl. J. Med. 350, 1629-1638 (2004).
60. Cohen, J. et al. Serial changes in plasma total cortisol, plasma free cortisol and tissue cortisol activity in patients with septic shock: an observational study. Shock 37, 28-33 (2011).
61. Zimmerman, J. J. et al. Real-time free cortisol quantification among critically ill children. Pediatr. Crit. Care Med. 12, 525-531 (2011).
62. Arafah, B. M., Nishiyama, F. J., Tlaygeh, H. & Hejal, R. Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol. J. Clin. Endocrinol. Metab. 92, 2965-2971 (2007).
63. Duplessis, C., Rascona, D., Cullum, M. & Yeung, E. Salivary and free serum cortisol evaluation. Mil. Med. 175, 340-346 (2010).
64. Cohen, J. et al. Measurement of tissue cortisol levels in patients with severe burns: a preliminary investigation. Crit. Care 13, R189 (2009).
65. Ilias, I. et al. Interstitial cortisol levels obtained by adipose tissue microdialysis in mechanically ventilated septic patients: correlations with total and free serum cortisol. Endocr. Abstr. 26, P15 (2011).
66. Llompart-Pou, J. A. et al. Correlation between brain interstitial and total serum cortisol levels in traumatic brain injury. A preliminary study. J. Endocrinol. Invest. 33, 368-372 (2010).
67. Marik, P. E., Gayowski, T. & Starzl, T. E. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit. Care Med. 33, 1254-1259 (2005).
68. O'Beirne, J. et al. Adrenal insufficiency in liver disease-what is the evidence? J. Hepatol. 47, 418-423 (2007).
69. Harry, R., Auzinger, G. & Wendon, J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int. 23, 71-77 (2003).
70. Tan, T. et al. Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease. J. Hepatol. 53, 841-848 (2010).
71. Brien, T. G. Pathophysiology of free cortisol in plasma. Ann. NY Acad. Sci. 538, 130-136 (1988).
72. Galbois, A. et al. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J. Hepatol. 52, 839-845 (2010).
73. Thevenot, T. et al. Assessment of adrenal function in cirrhotic patients using concentration of serum-free and salivary cortisol. Liver Int. 31, 425-433 (2011).
74. Fede, G. et al. Adrenocortical dysfunction in liver disease: a systematic review. Hepatology 55, 1282-1291 (2012).
75. Perogamvros, I. et al. Novel corticosteroid-binding globulin variant that lacks steroid binding activity. J. Clin. Endocrinol. Metab. 95, E142-E150 (2010).
76. Emptoz-Bonneton, A. et al. Novel human corticosteroid-binding globulin variant with low cortisol-binding affinity. J. Clin. Endocrinol. Metab. 85, 361-367 (2000).
77. Torpy, D. J. et al. Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. J. Clin. Endocrinol. Metab. 86, 3692-3700 (2001).
78. Torpy, D. J. et al. CBG Santiago: a novel CBG mutation. J. Clin. Endocrinol. Metab. 97, E151-E155 (2012).
79. Van Baelen, H., Brepoels, R. & De, M. P. Transcortin Leuven: a variant of human corticosteroid-binding globulin with decreased cortisol-binding affinity. J. Biol. Chem. 257, 3397-3400 (1982).
80. Perogamvros, I., Aarons, L., Miller, A. G., Trainer, P. J. & Ray, D. W. Corticosteroid-binding globulin regulates cortisol pharmacokinetics. Clin. Endocrinol. (Oxf.) 74, 30-36 (2011).
81. Brossaud, J., Barat, P., Gualde, D. & Corcuff, J. B. Cross reactions elicited by serum 17-OH progesterone and 11-desoxycortisol in cortisol assays. Clin. Chim. Acta 407, 72-74 (2009).
82. Monaghan, P. J. et al. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone. Ann. Clin. Biochem. 48, 441-446 (2011).
83. O'Shaughnessy, I. M., Raff, H. & Findling, J. W. Factitious Cushing's syndrome: discovery with use of a sensitive immunoradiometric assay for corticotropin. Endocr. Pract. 1, 327-329 (1995).
84. Roberts, R. F. & Roberts, W. L. Performance characteristics of five automated serum cortisol immunoassays. Clin. Biochem. 37, 489-493 (2004).
85. Siemens Healthcare Diagnostics Inc. Advia Centaur® Immunoassay Systems Customer Bulletin http://www.medical.siemens.com (2008).
86. Carvalho, V. M. The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 883-884, 50-58 (2012).
87. Hammond, G. L., Nisker, J. A., Jones, L. A. & Siiteri, P. K. Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J. Biol. Chem. 255, 5023-5026 (1980).
88. Jerkunica, I., Sophianopoulos, J. & Sgoutas, D. Improved ultrafiltration method for determining unbound cortisol in plasma. Clin. Chem. 26, 1734-1737 (1980).
89. Lentjes, E. G. et al. Free cortisol in serum assayed by temperature-controlled ultrafiltration before fluorescence polarization immunoassay. Clin. Chem. 39, 2518-2521 (1993).
90. Vogeser, M., Mohnle, P. & Briegel, J. Free serum cortisol: quantification applying equilibrium dialysis or ultrafiltration and an automated immunoassay system. Clin. Chem. Lab. Med. 45, 521-525 (2007).
91. Pretorius, C. J., Galligan, J. P., McWhinney, B. C., Briscoe, S. E. & Ungerer, J. P. Free cortisol method comparison: ultrafiltation, equilibrium dialysis, tracer dilution, tandem mass spectrometry and calculated free cortisol. Clin. Chim. Acta 412, 1043-1047 (2011).
92. Vining, R. F., McGinley, R. A. & Symons, R. G. Hormones in saliva: mode of entry and consequent implications for clinical interpretation. Clin. Chem. 29, 1752-1756 (1983).
93. Katz, F. H. & Shannon, I. L. Parotid fluid cortisol and cortisone. J. Clin. Invest. 48, 848-855 (1969).
94. Perogamvros, I., Owen, L. J., Keevil, B. G., Brabant, G. & Trainer, P. J. Measurement of salivary cortisol with liquid chromatography-tandem mass spectrometry in patients undergoing dynamic endocrine testing. Clin. Endocrinol. (Oxf.) 72, 17-21 (2010).
95. Umeda, T. et al. Use of saliva for monitoring unbound free cortisol levels in serum. Clin. Chim. Acta 110, 245-253 (1981).
96. Vining, R. F., McGinley, R. A., Maksvytis, J. J. & Ho, K. Y. Salivary cortisol: a better measure of adrenal cortical function than serum cortisol. Ann. Clin. Biochem. 20 (Pt 6), 329-335 (1983).
97. Chu, F. W. & Ekins, R. P. Detection of corticosteroid binding globulin in parotid fluids: evidence for the presence of both protein-bound and non-protein-bound (free) steroids in uncontaminated saliva. Acta Endocrinol. (Copenh.) 119, 56-60 (1988).
98. Hammond, G. L. & Langley, M. S. Identification and measurement of sex hormone binding globulin (SHBG) and corticosteroid binding globulin (CBG) in human saliva. Acta Endocrinol. (Copenh.) 112, 603-608 (1986).
99. Qureshi, A. C. et al. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Clin. Endocrinol. (Oxf.) 66, 632-635 (2007).
100. Simunková, K. et al. Comparison of total and salivary cortisol in a low-dose ACTH (Synacthen) test: influence of three-month oral contraceptives administration to healthy women. Physiol. Res. 57 (Suppl. 1), S193-S199 (2008).
101. Meulenberg, P. M. & Hofman, J. A. Differences between concentrations of salivary cortisol and cortisone and of free cortisol and cortisone in plasma during pregnancy and postpartum. Clin. Chem. 36, 70-75 (1990).
102. Sandeep, T. C. et al. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54, 872-879 (2005).
103. Li, Y., Peris, J., Zhong, L. & Derendorf, H. Microdialysis as a tool in local pharmacodynamics. AAPS J. 8, E222-E235 (2006).
104. Schäfer-Korting, M., Korting, H. C., Hiemstra, S. & Mutschler, E. Does cantharides blister fluid provide access to the peripheral compartment? Eur. J. Clin. Pharmacol. 23, 327-330 (1982).
105. Brunner, M. et al. Direct assessment of peripheral pharmacokinetics in humans: comparison between cantharides blister fluid sampling, in vivo microdialysis and saliva sampling. Br. J. Clin. Pharmacol. 46, 425-431 (1998).
106. Necela, B. M. & Cidlowski, J. A. Development of a flow cytometric assay to study glucocorticoid receptor-mediated gene activation in living cells. Steroids 68, 341-350 (2003).
107. Perogamvros, I., Kayahara, M., Trainer, P. J. & Ray, D. W. Serum regulates cortisol bioactivity by corticosteroid-binding globulin dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches. Clin. Endocrinol. (Oxf.), 75, 31-38 (2011).
108. Raivio, T., Palvimo, J. J., Kannisto, S., Voutilainen, R. & Jänne, O. A. Transactivation assay for determination of glucocorticoid bioactivity in human serum. J. Clin. Endocrinol. Metab. 87, 3740-3744 (2002).
109. Vermeer, H. et al. A novel specific bioassay for the determination of glucocorticoid bioavailability in human serum. Clin. Endocrinol. (Oxf.) 59, 49-55 (2003).
110. Baumann, G., Rappaport, G., Lemarchand-Béraud, T. & Felber, J. P. Free cortisol index: a rapid and simple estimation of free cortisol in human plasma. J. Clin. Endocrinol. Metab. 40, 462-469 (1975).
111. Coolens, J. L., Van, B. H. & Heyns, W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J. Steroid Biochem. 26, 197-202 (1987).
112. le Roux., C. W. et al. Free cortisol index as a surrogate marker for serum free cortisol. Ann. Clin. Biochem. 39, 406-408 (2002).
113. Ho, J. T. et al. Reduced maternal corticosteroid-binding globulin and cortisol levels in pre-eclampsia and gamete recipient pregnancies. Clin. Endocrinol. (Oxf.) 66, 869-877 (2007).
114. Pugeat, M. et al. Decreased immunoreactivity and binding activity of corticosteroid-binding globulin in serum in septic shock. Clin. Chem. 35, 1675-1679 (1989).
115. Vogeser, M., Groetzner, J., Küpper, C. & Briegel, J. Free serum cortisol during the postoperative acute phase response determined by equilibrium dialysis liquid chromatography-tandem mass spectrometry. Clin. Chem. Lab. Med. 41, 146-151 (2003).
116. Loriaux, L. Glucocorticoid therapy in the intensive care unit. N. Engl. J. Med. 350, 1601-1602 (2004).
117. McMaster, A. et al. Ultradian cortisol pulsatility encodes a distinct, biologically important signal. PLoS ONE 6, e15766 (2011).
118. Stavreva, D. A. et al. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat. Cell Biol. 11, 1093-1102 (2009).
119. Sakai, F. et al. Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast. J. Endocrinol. 76, 219-226 (1978).
120. Crave, J. C., Lejeune, H., Brebant, C., Baret, C. & Pugeat, M. Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells. J. Clin. Endocrinol. Metab. 80, 1283-1289 (1995).
121. Mihrshahi, R., Lewis, J. G. & Ali, S. O. Hormonal effects on the secretion and glycoform profile of corticosteroid-binding globulin. J. Steroid Biochem. Mol. Biol. 101, 275-285 (2006).
122. Caron, P., Bennet, A., Barousse, C., Nisula, B. C. & Louvet, J. P. Effects of hyperthyroidism on binding proteins for steroid hormones. Clin. Endocrinol. (Oxf.) 31, 219-224 (1989).
123. Feldman, D., Mondon, C. E., Horner, J. A. & Weiser, J. N. Glucocorticoid and estrogen regulation of corticosteroid-binding globulin production by rat liver. Am. J. Physiol. 237, E493-E499 (1979).
124. Schlechte, J. A. & Hamilton, D. The effect of glucocorticoids on corticosteroid binding globulin. Clin. Endocrinol. (Oxf.) 27, 197-203 (1987).